Pre-treatment erythropoietin levels cannot be used to predict individual response to epoetin alfa in anaemic cancer patients

Current Medical Research and Opinion, Supplement

Volumn 21, Issue 2, 2005, Pages

  Littlewood, T J ^a   Zagari, M ^a   Pallister, P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; ANTINEOPLASTIC AGENT; PLACEBO;

ALGORITHM; ANEMIA; ARTICLE; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FACTORIAL ANALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; BLOOD; CHEMICALLY INDUCED DISORDER; DOUBLE BLIND PROCEDURE; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM;

ANEMIA; ANTINEOPLASTIC AGENTS; DOUBLE-BLIND METHOD; EPOETIN ALFA; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PLACEBOS;

EID: 24044488635     PISSN: 01419951     EISSN: None     Source Type: Journal    
DOI: 10.1185/174234305X13824     Document Type: Article

References (8)

1. Vogelzang NJ, Breitbart W, Cella D, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripartite assessment survey. Semin Hematol. 1997;34:4-12
2. Mercadente S. Pharmacotherapy of anemia in cancer patients. Exp Opin Pharmacother 2001;2:1949-61.
3. Littlewood TJ, Bajetta E, Nortier JWR, et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2001;19:2865-74
4. Ludwig H, Fritz E, Leitgeb C, et al. Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumours. Ann Oncol 1993;4:161-7.
5. Ludwig H, Fritz E, Leitgeb C, et al. Prediction of response to erythropoietin treatment in chronic anemia of cancer. Blood 1994;84:1058-63.
6. Abels RI, Larholt KM, Krantz KD, et al. recombinant human erythropoietin (rHuEPO) for the treatment of the anemia of cancer. The Oncologist 1996;1:140-50.
7. Dammacco F, Castoldi G, Rödjer S. Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma. Br J Haematol. 2001;113:172-9
8. Cazzola M, Ponchio L, Pedrotti C, et al. Prediction of response to recombinant human erythropoietin (rHuEPO) in anemia of malignancy. Haematologica 1996;81:434-41